165 related articles for article (PubMed ID: 2498661)
1. Immune activation in measles.
Griffin DE; Ward BJ; Jauregui E; Johnson RT; Vaisberg A
N Engl J Med; 1989 Jun; 320(25):1667-72. PubMed ID: 2498661
[TBL] [Abstract][Full Text] [Related]
2. Measles encephalomyelitis--clinical and immunologic studies.
Johnson RT; Griffin DE; Hirsch RL; Wolinsky JS; Roedenbeck S; Lindo de Soriano I; Vaisberg A
N Engl J Med; 1984 Jan; 310(3):137-41. PubMed ID: 6197651
[TBL] [Abstract][Full Text] [Related]
3. Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease.
Griffin DE; Ward BJ; Jauregui E; Johnson RT; Vaisberg A
J Infect Dis; 1990 Mar; 161(3):449-53. PubMed ID: 2107264
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection.
Ward BJ; Johnson RT; Vaisberg A; Jauregui E; Griffin DE
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):236-48. PubMed ID: 1914259
[TBL] [Abstract][Full Text] [Related]
5. Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination.
Aronsson B; Troye-Blomberg M; Smedman L
J Clin Lab Immunol; 2004-2005; 53():1-12. PubMed ID: 16805321
[TBL] [Abstract][Full Text] [Related]
6. Immune activation during measles: beta 2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease.
Griffin DE; Ward BJ; Juaregui E; Johnson RT; Vaisberg A
J Infect Dis; 1992 Nov; 166(5):1170-3. PubMed ID: 1402029
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection.
Vinante F; Krampera M; Morosato L; Rigo A; Romagnani S; Pizzolo G
Haematologica; 1999 Aug; 84(8):683-9. PubMed ID: 10457402
[TBL] [Abstract][Full Text] [Related]
8. Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination.
Pauksen K; Sjölin J; Linde A; Alm G; Andersson B; Lönnerholm G; Ljungman P
Bone Marrow Transplant; 1997 Aug; 20(4):317-23. PubMed ID: 9285547
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA.
Dhiman N; Ovsyannikova IG; Howe RC; Ryan JE; Jacobson RM; Poland GA
J Immunol Methods; 2004 Apr; 287(1-2):217-25. PubMed ID: 15099769
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
Marcante R; Cavedon G
Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
[TBL] [Abstract][Full Text] [Related]
11. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG
J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259
[TBL] [Abstract][Full Text] [Related]
12. Cellular immune responses during complicated and uncomplicated measles virus infections of man.
Hirsch RL; Griffin DE; Johnson RT; Cooper SJ; Lindo de Soriano I; Roedenbeck S; Vaisberg A
Clin Immunol Immunopathol; 1984 Apr; 31(1):1-12. PubMed ID: 6230187
[TBL] [Abstract][Full Text] [Related]
13. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
14. CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective.
Tishon A; Lewicki H; Andaya A; McGavern D; Martin L; Oldstone MB
Virology; 2006 Mar; 347(1):234-45. PubMed ID: 16529787
[TBL] [Abstract][Full Text] [Related]
15. [Serum interleukin-2 receptor in patients with Kawasaki disease].
Matsubara T
Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous proliferation of peripheral mononuclear cells in natural measles virus infection: identification of dividing cells and correlation with mitogen responsiveness.
Ward BJ; Johnson RT; Vaisberg A; Jauregui E; Griffin DE
Clin Immunol Immunopathol; 1990 May; 55(2):315-26. PubMed ID: 2323109
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
[TBL] [Abstract][Full Text] [Related]
18. Measles encephalomyelitis: lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination.
Gendelman HE; Wolinsky JS; Johnson RT; Pressman NJ; Pezeshkpour GH; Boisset GF
Ann Neurol; 1984 Apr; 15(4):353-60. PubMed ID: 6204579
[TBL] [Abstract][Full Text] [Related]
19. Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA.
Moench TR; Griffin DE; Obriecht CR; Vaisberg AJ; Johnson RT
J Infect Dis; 1988 Aug; 158(2):433-42. PubMed ID: 3042879
[TBL] [Abstract][Full Text] [Related]
20. Immune response to measles vaccine in Peruvian children.
Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
